|
BensulfoidDrug - Bensulfoid The trade name of the product as shown on the labeling.
Dosage -
POWDER; TOPICAL
Active Ingredient(s) -
Sulfur
Strength -
33.32%
Applicant -
POYTHRESS
New Drug Application (NDA) Number -
002918
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
William P Poythress And Co Inc
Bensulfoid
Gantrisin Eq 4% Base Solution/drops; Ophthalmic
Sulfisoxazole Diolamine Eq 4% Base Solution/drops; Ophthalmic Diasone Sodium 165mg Tablet, Delayed Release; Oral Bensulfoid 33.32% Powder; Topical Sulsoxin 500mg Tablet; Oral Lipo Gantrisin Eq 1gm Base/5ml Emulsion; Oral Gantrisin Pediatric Eq 500mg Base/5ml Suspension; Oral Gantrisin Eq 500mg Base/5ml Syrup; Oral Gantrisin Eq 400mg Base/ml Injectable; Injection Gantrisin Eq 4% Base Ointment; Ophthalmic NewDrugInformation |